New Products

Premium

LifeSensors last week launched its Chop2 Reporter Assay Kits for deubiquitylases and announced the "imminent launch" of its ubiquitin ligase assay kits.

The technologies are licensed from Progenra which developed them.

In a statement, LifeSensors said that the conjugation and deconjugation of ubiquitin and ubiquitin-like proteins are of "intense" interest to academia and pharma "due to their central roles in human health and disease," and research in such pathways are likely to lead to "many pioneering drugs."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.